NCT02625194 is a NA clinical trial of Oxygen in Lumbar Spinal Stenosis, sponsored by Yonsei University.

Who is sponsoring NCT02625194?

NCT02625194 is sponsored by Yonsei University.

What drugs are being tested in NCT02625194?

Interventions in NCT02625194: Oxygen.

What condition does NCT02625194 study?

NCT02625194 studies Lumbar Spinal Stenosis.

Is NCT02625194 still recruiting?

NCT02625194 is currently completed. Last updated 9 July 2019.

Last reviewed 2019-07-09 · How we verify

NCT02625194

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Utility of Oxygen Insufflation During Flexible Fiberoptic Bronchoscope-guided Intubation

Completed NA Last updated 9 July 2019

What this trial tests

NA trial testing Oxygen in Lumbar Spinal Stenosis in 36 participants. Completed in 4 September 2017.

Timeline

1 January 2016

Primary endpoint
4 September 2017

4 September 2017

Quick facts

Lead sponsor	Yonsei University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	36
Start date	1 January 2016
Primary completion	4 September 2017
Estimated completion	4 September 2017
Sites	1 location across South Korea

Drugs / interventions tested

Oxygen — full drug profile →

Conditions studied

Lumbar Spinal Stenosis — all drugs for Lumbar Spinal Stenosis →

Sponsor

Yonsei University

Who can join

Adults 20 to 60, any sex, with Lumbar Spinal Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study investigate the utility of continuous oxygen insufflation during fiberoptic bronchoscope-guided intubation. One group receives oxygen via suction channel of fiberoptic bronchoscope during intubation. The other group does not receive oxygen during fiberoptic bronchoscope-guided intubation. Then, the velocity of deoxygenation difference of PaO2(baseline

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Utility of oxygen insufflation through working channel during fiberoptic intubation in apneic patients: a prospective randomized controlled study.
Roh GU, Kang JG, Han JY, Chang CH. · · 2020 · cited 8× · PMID 33167909 · DOI 10.1186/s12871-020-01201-9
Utility of oxygen insufflation through working channel during fiberoptic intubation in apneic patients: a prospective randomized controlled study
Roh GU, Kang JG, Han JY, Chang CH. · · 2020 · DOI 10.21203/rs.3.rs-50531/v4

Verify or expand the search:

Other trials of Oxygen

Trials testing the same drug.

NCT06327373 — A Feasibility Study of Supplemental Oxygen to Improve Pulmonary Hypertension in People With Intradialytic Hypoxemia · Phase 1, PHASE2 · not yet recruiting
NCT07464730 — Postoperative High-flow Nasal Oxygenation After High-risk Surgery in the Frail Adult · NA · not yet recruiting
NCT06498908 — Intracervical Balloon Placement With Nitrous Oxide Administration · Phase 3 · withdrawn
NCT07245628 — A Trial of Self-Adjusted Nitrous Versus Placebo During Office Vasectomy · EARLY_PHASE1 · recruiting
NCT07369232 — Cerebral Hemodynamic Effects of Oxygen and Antioxidants (CHEOXANT) · NA · recruiting

Other recruiting trials for Lumbar Spinal Stenosis

Currently open trials in the same condition.

NCT07489001 — Opioid Free and Opioid Based Anesthesia in Elective Lumbar Spine Surgery · recruiting
NCT07233798 — Presence of Dural Pulsation in Patients Diagnosed With Lumbar Spinal Stenosis · recruiting
NCT07281625 — Decompressive Laminectomy Versus Laminectomy With Transpedicular Fixation in Lumbar Spinal Stenosis · EARLY_PHASE1 · recruiting
NCT07001982 — Lumbar Spinal Stenosis and Central Sensitization · recruiting
NCT06959355 — Frailty and Associated Factors in Lumbar Spinal Stenosis · recruiting

Other Yonsei University trials

Trials by the same sponsor.

NCT07547592 — Gemcitabine and Docetaxel With or Without Bevacizumab (Onbevzi) for Soft Tissue Sarcoma · Phase 2 · not yet recruiting
NCT07524101 — Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD · NA · not yet recruiting
NCT07506629 — Adductor Canal Block Methods in Bilateral Total Knee Arthroplasty · NA · not yet recruiting
NCT07515716 — Effects of High Flow Humidified Oxygen on Umbilical Artery Acid-base Balance in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
NCT07507188 — Collaborative Clinical-translational Cohort of Amivantamab Plus Lazertinib and Amivantamab Plus Chemotherapy in Patients · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02625194 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yonsei University
Last refreshed: 9 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02625194.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing